Acute Myeloid Leukemia With Myelodysplasia-Related Changes

DrugDrug NameDrug Description
DB00694DaunorubicinAn anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia.
DrugDrug NamePhaseStatusCount
DB00987Cytarabine1 / 2Recruiting1
DB01177Idarubicin1 / 2Recruiting1
DB11759Pevonedistat1 / 2Recruiting1
DB02379Beta-D-Glucose2Completed1
DB01008Busulfan2Completed1
DB01008Busulfan2Recruiting1
DB00631Clofarabine2Recruiting1
DB06189Clofarabine2Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB00987Cytarabine2Completed1
DB00987Cytarabine2Recruiting2
DB00694Daunorubicin2Completed1
DB00694Daunorubicin2Recruiting2
DB01262Decitabine2Completed1
DB00773Etoposide2Completed1
DB00099Filgrastim2Completed1
DB01073Fludarabine2Recruiting1
DB11978Glasdegib2Recruiting1
DB00888Mechlorethamine2Recruiting1
DB15721Natural Killer Cell2Recruiting1
DB00073Rituximab2Recruiting1
DB00987CytarabineNot AvailableCompleted1
DB00694DaunorubicinNot AvailableCompleted1